Loading viewer...
investor_presentation
Format: PDF investor_presentation
Wave Life Sciences is building a leading genetic medicines company leveraging stereopure oligonucleotides and novel backbone chemistry modifications. The company targets multiple disease areas including ALS, frontotemporal dementia, Huntington's disease, Duchenne muscular dystrophy, and Alpha-1 antitrypsin deficiency through its innovative transcriptome-targeting platform.
investor_presentation
42 Pages
investor_presentation
48 Pages
Inovio Pharmaceuticals
J.B. Hunt Transport Services 2023 Investor Presentation
investor_presentationinvestor_presentation
27 Pages
J.B. Hunt Transport Services, Inc.
investor_presentation
BT Group